−0.004 GBP
−6.69 M GBP
0.00 GBP
1.27 B
About HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Sector
Industry
CEO
Vladislav Sandler
Website
Headquarters
London
Founded
2013
ISIN
GB00BYX3WZ24
FIGI
BBG00BDKH4D5
HemoGenyx Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of a suite of products to address current problems associated with the treatment of blood disorders such as cancers and autoimmune diseases, with bone marrow, or hematopoietic stem cell, transplants, and with viral infections. It operates through the United Kingdom and United States geographical segments. The company was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HEMO is 1.512 GBX — it has decreased by −5.84% in the past 24 hours. Watch HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stocks are traded under the ticker HEMO.
HEMO stock has risen by 33.86% compared to the previous week, the month change is a −1.03% fall, over the last year HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 has showed a −39.29% decrease.
HEMO reached its all-time high on Aug 26, 2020 with the price of 15.388 GBX, and its all-time low was 0.950 GBX and was reached on Apr 2, 2020. View more price dynamics on HEMO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HEMO stock is 18.20% volatile and has beta coefficient of 0.23. Track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock price on the chart and check out the list of the most volatile stocks — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 there?
Today HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 has the market capitalization of 20.12 M, it has increased by 42.91% over the last week.
Yes, you can track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
HEMO net income for the last half-year is −2.81 M GBP, while the previous report showed −2.37 M GBP of net income which accounts for −18.71% change. Track more HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 financial stats to get the full picture.
No, HEMO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 22.00 employees. See our rating of the largest employees — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 on this list?
Like other stocks, HEMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock shows the sell signal. See more of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.